Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin Ainjections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome
The DOI matches its Crossref record.
Abstract
What's known on the subject? and What does the study add?: A single set of botulinum toxin A ( BoNT‐A ) injections relieves clinical symptoms of interstitial cystitis/bladder pain syndrome ( IC/BPS ), but lacks long‐term effect. An inadequate anti‐inflammatory effect is likely to cause treatment failure. The study shows that chronic inflammation and apoptotic signalling molecules are significantly reduced after repeated intravesical BoNT‐A injection in patients with IC/BPS . It also shows that repeated BoNT‐A injections are necessary to achieve greater success in the treatment of IC/BPS . Objective: To investigate the mechanisms of action of botulinum toxin A ( BoNT‐A ) treatment on interstitial cystitis/bladder pain syndrome ( IC/BPS ). Patients and Methods: A total of 23 women with IC/BPS who received single intravesical BoNT‐A injection were studied. Among them, 11 received three repeated injections every 6 months to improve their symptoms. Bladder biopsy was obtained before each BoNT‐A injection and the clinical symptoms and urodynamic variables were recorded. Immunohistochemical ( IHC ) staining for TUNEL and mast cell activity, and western blotting analysis of tryptase, cytokines, B ax and phospho‐p38 (p‐p38) were carried out. We compared the clinical results and IHC data among baseline, single or repeated BoNT‐A treatments. Results: Single BoNT‐A injection improved clinical symptoms, pain score and daytime urinary frequency. Mast cell activity and apoptotic cell count did not decrease significantly, while B ax and p‐p38, but not tryptase, decreased significantly after a single BoNT‐A injection. The 11 patients who received three repeated BoNT‐A injections had significantly lower pain scores than the remaining patients (mean [SD]: 5.80 [2.27] vs. 3.03 [2.30], P = 0), glomerulation degree (mean [SD]: 1.80 [1.06] vs. 1.20 [1.06], P = 0.026) and global response scores (mean [SD]: 0.30 [0.92] vs. 1.20 [1.06], P = 0) after treatment. Tryptase, B ax, p‐p38 and apoptotic cell counts all decreased significantly. 25‐k D synaptosomal‐associated protein also decreased after BoNT‐A treatments, which confirmed the therapeutic effect of repeated BoNT‐A injections. Conclusions: Chronic inflammation and apoptotic signalling molecules were significantly reduced after repeated BoNT‐A injections in patients with IC/BPS . The IHC improvement was associated with clinical symptom improvement. Repeated BoNT‐A injections are necessary to achieve a greater success rate in the treatment of IC/BPS .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Repeated intravesical BoNT-A injections can reduce mast cell activity and apoptotic signaling molecule levels, thereby promoting the expression of Ki-67 and E-cadherin [43].”
From The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 26
- 10.1016/j.urology.2003.10.034 · doi:10.1016/j.urology.2003.10.034
- 10.1007/s11934-008-0054-8 · doi:10.1007/s11934-008-0054-8
- 10.1016/j.cellsig.2008.06.004 · DOI
- 10.1016/j.urology.2004.06.073 · doi:10.1016/j.urology.2004.06.073
- 10.1111/j.1464-410X.2007.07312.x · doi:10.1111/j.1464-410x.2007.07312.x
- 10.1016/j.urology.2007.04.038 · DOI · Paper page
- 10.1016/j.eururo.2005.12.002 · DOI
- 10.1016/j.juro.2007.10.032 · DOI
- 10.1111/j.1464-410X.2009.08495.x · DOI · Paper page
- 10.1016/S0090-4295(99)80333-1 · DOI · Paper page
- 10.1111/j.1442-2042.2009.02326.x · DOI · Paper page
- 10.1016/j.urology.2004.10.071 · DOI · Paper page
- Kaczmarek E, 2004, Techniques of image analysis for quantitative immunohistochemistry, Rocz Akad Med Bialymst, 49, 155
- 10.1016/j.urology.2006.03.083 · DOI
- 10.1016/j.juro.2007.09.022 · DOI
- 10.1111/j.1464-410X.2009.08467.x · doi:10.1111/j.1464-410x.2009.08467.x
- 10.1007/s11934-006-0051-8 · DOI
- 10.1007/s00345-007-0174-7 · doi:10.1007/s00345-007-0174-7
- 10.1111/j.1464-410X.2010.09911.x · DOI · Paper page
- 10.1016/j.urology.2011.09.049 · DOI · Paper page
- 10.1016/j.bbamcr.2006.02.002 · DOI
- 10.1097/01.ju.0000135009.55905.cb · DOI · Paper page
- 10.1152/ajplung.00057.2006 · DOI
- 10.1074/jbc.272.30.18518 · DOI · Paper page
- 10.1152/ajprenal.00010.2007 · DOI
- 10.1111/j.1464-410X.2008.08097.x · DOI
Cited by
Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome: AUA Guideline Amendment
Hanno, P. M., Erickson, D., Moldwin, R., & Faraday, M. M. (2015) · Journal of Urology · doi:10.1016/j.juro.2015.01.086 · Cited by 692
Jhang, J.-F., & Kuo, H.-C. (2016) · International Neurourology Journal · doi:10.5213/inj.1632712.356 · Cited by 99
Self-citationRETRACTED: Skin boosters: Definitions and varied classifications
Yi, K., Winayanuwattikun, W., Kim, S., Wan, J., Vachatimanont, V., Putri, A. I., Hidajat, I. J., Yogya, Y., & Pamela, R. (2024) · Skin Research and Technology · doi:10.1111/srt.13627 · Cited by 74
RetractedKim, M. J., Kim, J. H., Cheon, H. I., Hur, M. S., Han, S. H., Lee, Y. W., Choe, Y. B., & Ahn, K. J. (2019) · Dermatologic Surgery · doi:10.1097/dss.0000000000001819 · Cited by 69
Yu, W.-R., Jhang, J.-F., Jiang, Y.-H., & Kuo, H.-C. (2024) · Biomedicines · doi:10.3390/biomedicines12092051 · Cited by 39
Self-citation
Metadata
- Authors
- Shie, J., Liu, H., Wang, Y., & Kuo, H.
- Affiliations
- Department of Urology Buddhist Tzu Chi General Hospital and Tzu Chi University
- Venue
- BJU International
- Publisher
- Wiley
- Published
- 2012-09-03
- Volume
- 111
- Issue
- 4
- Pages
- 638-646
- ISSN
- 1464-4096
- 1464-410X
- Cited by
- 67
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin Ainjections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. https://app.cochat.ai/papers/10.1111/j.1464-410x.2012.11466.x
- The paper
- Shie, J., Liu, H., Wang, Y., & Kuo, H. (2013). Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin Ainjections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. BJU International. https://doi.org/10.1111/j.1464-410x.2012.11466.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.